EYEGAlliance Bernstein - AB Corporate Bond ETF

NAS · US · Healthcare · Biotechnology
34.49USD-0.46%Mkt Cap: P/E:

The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers.…

Key Statistics

Company
Market Cap
Enterprise Value
Revenue (TTM)
Gross Profit
Net Income (TTM)
Revenue/Share
Last Price34.49 USD
Fiscal Year End
MR Quarter
Employees
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B
EPS (TTM)
EPS (Forward)
52W Range
34.462% of range36.63
52W High36.63 USD
52W Low34.46 USD
Profitability
Gross Margin
Oper. Margin
EBITDA Margin
Profit Margin
ROE
ROA
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio
Quick Ratio
Book Value/Sh
Cash/Share
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield5.02%
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float
Insiders
Institutions
Technical
SMA 5034.89 (-1.1%)
SMA 20035.45 (-2.7%)
Beta
S&P 52W Chg
Avg Vol (30d)399
Avg Vol (10d)590
Technical Indicators
RSI (14)42.4
MACD-0.0966
MACD Signal-0.1115
MACD Hist.+0.0149
BB Upper34.74 USD
BB Middle34.59 USD
BB Lower34.44 USD
BB Width0.86%
ATR (14)0.1001 USD
Vol Ratio (20d)0.59x